Tag: Health and Medical technology

TOPLINE: Use of the glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide and liraglutide is associated with a lower risk of alcohol use disorder (AUD)-related hospitalizations compared to traditional AUD medications, a…